The Increasing Cases Of Chronic Diseases Such As Cancer Or Malignancy And Other Infectious Diseases To Boost The Growth Of Immunoassay Instruments Market
Immunoassay Instruments Market, by Product Type (Analyzers (Semi-automated and Automated), Reagents (Enzymatic Markers and Luminophore Markers), and Consumables), by Application (Oncology, Endocrinology, Therapeutic Drug Monitoring, Autoimmune Disease, Cardiology, Infectious Disease, and Others), by End User (Pharmaceutical, Hospitals, Biotechnology Companies, Clinical Laboratories, and Others), and by Region (Europe, North America, Middle East, Latin America, Asia Pacific, and Africa) - Outlook, Size, Share, and Opportunity Analysis, 2021 – 2028
The global Immunoassay Instruments Market is estimated to be valued at US$ XX million in XXX and is expected to exhibit a CAGR of XX% over the forecast period, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The immunoassay instrument is utilized to conduct the biochemical tests to identify or measure specific proteins or any other substances from their properties such as the antibodies. There are five types of immunoassays they are EIA, RIA, CIA, CLIA and FIA, which are utilized during the diagnosis.
Competitive Landscape:
Key players involved in the global Immunoassay Instruments Market are F. Hoffmann-La Roche AG, DiaSorin S.p.A., Tosoh Corporation, Maccura Biotechnology Co., Ltd., Beckman Coulter Inc., Siemens Healthineers, Abbott Laboratories, Inova Diagnostics, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Ortho Clinical Diagnostic.
Key Market Drivers:
The increasing cases of chronic diseases such as cancer or malignancy and other infectious diseases is anticipated to augment the growth of the global immunoassay instruments for market. For instance, as per WHO above 30 various types of diseases have been observed from past twenty years
The rising HIV cases are also anticipated to boost the growth of the global Immunoassay Instruments Market. As per CDC, approximately 36,801 people were diagnosed with HIV and 1,189,700 are suffering from HIV in the United States in the year 2019.
Covid-19 Impact Analysis:
The outbreak of Covid-19 has positively affected the growth of the global immunoassay instruments for market as it was very necessary and essential to understand the antigen profile and the immune response in the patients suffering from Covid-19. It was also observed that people who were suffering from Covid-19 had notable above average IgG antibody titers over all the antibodies in a profiling conducted in US amidst the elders and kids.
Key Takeaways:
The global Immunoassay Instruments Market is expected to exhibit a CAGR of XX % during the forecast period due to the rising product development continuously. For instance, the clearance of iStat cardiac Troponin I test cartridge by the United States Food and Drug Administration which employs ELISA.
Among region North America, Asia Pacific and Europe are anticipated to witness robust growth in the global immunoassay instruments for market due to the increasing R&D developments, frequent approvals and quick launches, rising infectious diseases and rising research activities. For instance, in April 2018, Siemens Healthcare GmbH declared first fixation of Atellica immunoassay solution (ASI) with the Aptio Automation in the US.

Comments
Post a Comment